2019 AMI Online Salon

Larazotide Acetate (INN-202) Mechanism of Action

Project Detail

  • Company/Institution: Nucleus Medical Media

  • Entrant Name: Nobles Green

  • Membership Type: Company/Corporation Submission

  • Other Contributors:                         

  • Address: Kennesaw,GA

  • Client: Innovate Biopharmaceuticals

  • Medium/software used: Cinema 4D, After Effects

  • Final presentation format: Animation on website

  • Primary Audience: General public, Potential clinical trial enrollees

Project Description

The animation provides a simplified depiction of celiac disease and the potential mechanism in which Larazotide Acetate can provide treatment.  The viewer is guided through the human gut to see how gliadin peptides can trigger an autoimmune response in people with gluten sensitivities. In contrast, Larazotide can block the interactions of these peptides with the gut lumen and allow the colon to eliminate these elements out of the body.